Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 39 | $27.49 | $1,072.11 |
DisclosureSEC source: 0000078003-07-000124 · can1512.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,859 Underlying: Common Stock · 39 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 35 | $27.49 | $962.15 |
DisclosureSEC source: 0000078003-07-000123 · bag1511.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,302 Underlying: Common Stock · 35 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 48 | $27.49 | $1,319.52 |
DisclosureSEC source: 0000078003-07-000125 · fec1513.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,344 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 99 | $27.49 | $2,721.51 |
DisclosureSEC source: 0000078003-07-000126 · kin1514.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,516 Underlying: Common Stock · 99 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 192 | $27.49 | $5,278.08 |
DisclosureSEC source: 0000078003-07-000127 · lam1515.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,225 Underlying: Common Stock · 192 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 297 | $27.49 | $8,164.53 |
DisclosureSEC source: 0000078003-07-000128 · lev1516.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,763 Underlying: Common Stock · 297 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 141 | $27.49 | $3,876.09 |
DisclosureSEC source: 0000078003-07-000129 · rea1517.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,810 Underlying: Common Stock · 141 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 300 | $27.49 | $8,247.00 |
DisclosureSEC source: 0000078003-07-000130 · she1518.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,732 Underlying: Common Stock · 300 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2007 Filed Jun 1, 2007 18:36 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $27.49 | $1,237.05 |
DisclosureSEC source: 0000078003-07-000131 · wax1519.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,164 Underlying: Common Stock · 45 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 69 | $27.10 | $1,869.90 |
DisclosureSEC source: 0000078003-07-000113 · bag1502.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,267 Underlying: Common Stock · 69 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 112 | $27.10 | $3,035.20 |
DisclosureSEC source: 0000078003-07-000114 · can1503.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: Common Stock · 112 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 265 | $27.10 | $7,181.50 |
DisclosureSEC source: 0000078003-07-000115 · fec1504.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,296 Underlying: Common Stock · 265 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 285 | $27.10 | $7,723.50 |
DisclosureSEC source: 0000078003-07-000116 · kin1505.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,417 Underlying: Common Stock · 285 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 777 | $27.10 | $21,056.70 |
DisclosureSEC source: 0000078003-07-000117 · lam1506.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,033 Underlying: Common Stock · 777 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 969 | $27.10 | $26,259.90 |
DisclosureSEC source: 0000078003-07-000118 · lev1507.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,466 Underlying: Common Stock · 969 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 487 | $27.10 | $13,197.70 |
DisclosureSEC source: 0000078003-07-000119 · rea1508.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,669 Underlying: Common Stock · 487 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 1,261 | $27.10 | $34,173.10 |
DisclosureSEC source: 0000078003-07-000120 · she1509.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,432 Underlying: Common Stock · 1,261 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2007 Filed May 16, 2007 19:54 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 89 | $27.10 | $2,411.90 |
DisclosureSEC source: 0000078003-07-000121 · wax1510.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,119 Underlying: Common Stock · 89 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 08, 2007 Filed May 8, 2007 19:48 UTC |
LEVIN ALAN GSenior Vice President
|
SaleCommon Stock | 14,210 | $27.34 | $388,501.40 |
DisclosureSEC source: 0000078003-07-000109 · lev1501.xml · nonDerivative · entry 4 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,061 Read SEC document |
| May 07, 2007 Filed May 8, 2007 19:48 UTC |
LEVIN ALAN GSenior Vice President
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000078003-07-000109 · lev1501.xml · derivative · entry 6 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. Read SEC document |
| May 07, 2007 Filed May 8, 2007 19:48 UTC |
LEVIN ALAN GSenior Vice President
|
SaleCommon Stock | 57,386 | $27.12 | $1,556,308.32 |
DisclosureSEC source: 0000078003-07-000109 · lev1501.xml · nonDerivative · entry 3 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,271 Read SEC document |
| May 07, 2007 Filed May 8, 2007 19:48 UTC |
LEVIN ALAN GSenior Vice President
|
SaleCommon Stock | 84,552 | $26.96 | $2,279,521.92 |
DisclosureSEC source: 0000078003-07-000109 · lev1501.xml · nonDerivative · entry 2 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,657 Read SEC document |
| May 07, 2007 Filed May 8, 2007 19:48 UTC |
LEVIN ALAN GSenior Vice President
|
Exercise / conversionCommon Stock | 90,000 | $18.35 | $1,651,500.00 |
DisclosureSEC source: 0000078003-07-000109 · lev1501.xml · nonDerivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
BAGGER RICHARD HSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 36 | $26.46 | $952.56 |
DisclosureSEC source: 0000078003-07-000093 · bag1492.xml · derivative · entry 1 BAGGER RICHARD H · CIK 0001372907 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,198 Underlying: Common Stock · 36 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 41 | $26.46 | $1,084.86 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · derivative · entry 7 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,708 Underlying: Common Stock · 41 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
FECZKO JOSEPH MSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $26.46 | $1,375.92 |
DisclosureSEC source: 0000078003-07-000095 · fec1493.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,031 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
KINDLER JEFFREY BDirector · Chairman & CEO
|
GrantPhantom Stock Units SSP · Derivative | 103 | $26.46 | $2,725.38 |
DisclosureSEC source: 0000078003-07-000096 · kin1494.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,132 Underlying: Common Stock · 103 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 207 | $26.46 | $5,477.22 |
DisclosureSEC source: 0000078003-07-000097 · lam1495.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,256 Underlying: Common Stock · 207 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:42 UTC |
WAXMAN ALLEN PSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 47 | $26.46 | $1,243.62 |
DisclosureSEC source: 0000078003-07-000101 · wax1499.xml · derivative · entry 1 WAXMAN ALLEN P · CIK 0001372913 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030 Underlying: Common Stock · 47 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 318 | $26.46 | $8,414.28 |
DisclosureSEC source: 0000078003-07-000098 · lev1496.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,497 Underlying: Common Stock · 318 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
READ IAN CSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 150 | $26.46 | $3,969.00 |
DisclosureSEC source: 0000078003-07-000099 · rea1497.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,182 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:41 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 322 | $26.46 | $8,520.12 |
DisclosureSEC source: 0000078003-07-000100 · she1498.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,171 Underlying: Common Stock · 322 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:51 UTC |
MCLEOD MARY SSenior Vice President
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0000078003-07-000102 · mcl1500.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2017-04-29 Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:51 UTC |
MCLEOD MARY SSenior Vice President
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000102 · mcl1500.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| April 27, 2007 Filed Apr 30, 2007 18:55 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 29,086 | $26.61 | $773,978.46 |
DisclosureSEC source: 0000078003-07-000092 · ste1490.xml · nonDerivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,584,227 Read SEC document |
| April 27, 2007 Filed Apr 30, 2007 18:55 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 55,856 | $26.62 | $1,486,886.72 |
DisclosureSEC source: 0000078003-07-000092 · ste1490.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,613,313 Read SEC document |
| April 27, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,052 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · derivative · entry 6 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,052 shares Expires 2007-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 28,1998. Read SEC document |
| April 27, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
SaleCommon Stock | 7,269 | $26.50 | $192,628.50 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · nonDerivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,712 Read SEC document |
| April 27, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
SaleCommon Stock | 20,477 | $26.53 | $543,254.81 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · nonDerivative · entry 3 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,981 Read SEC document |
| April 27, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
SaleCommon Stock | 8,052 | $26.56 | $213,861.12 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,458 Read SEC document |
| April 27, 2007 Filed May 1, 2007 20:41 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
Exercise / conversionCommon Stock | 8,052 | $18.35 | $147,754.20 |
DisclosureSEC source: 0000078003-07-000094 · can1491.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,510 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
Ausiello Dennis ADirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000082 · aus1481.xml · derivative · entry 1 Ausiello Dennis A · CIK 0001381994 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,055 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
BROWN MICHAEL SDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000083 · bro1482.xml · derivative · entry 1 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,326 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
BURNS M ANTHONYDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000084 · bur1483.xml · derivative · entry 1 BURNS M ANTHONY · CIK 0001174476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,464 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
BURT ROBERT NDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000085 · bur1484.xml · derivative · entry 1 BURT ROBERT N · CIK 0001051322 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,204 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
CORNWELL W DONDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000086 · cor1485.xml · derivative · entry 1 CORNWELL W DON · CIK 0001174477 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,802 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
GRAY III WILLIAM HDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000087 · gra1480.xml · derivative · entry 1 GRAY III WILLIAM H · CIK 0001140889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,393 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
HORNER CONSTANCE JDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000088 · hor1486.xml · derivative · entry 1 HORNER CONSTANCE J · CIK 0001174479 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,464 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
HOWELL WILLIAM RDirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000089 · how1487.xml · derivative · entry 1 HOWELL WILLIAM R · CIK 0001174480 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,887 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| April 26, 2007 Filed Apr 30, 2007 18:55 UTC |
LORCH GEORGE ADirector
|
GrantPhantom Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000090 · lor1488.xml · derivative · entry 1 LORCH GEORGE A · CIK 0001174481 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,769 Underlying: Common Stock · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors. F3 · derivative.exercise_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. F3 · derivative.expiration_date: These units are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.